Clinical Trial Results:
Bortezomib consolidation in patients with myeloma following treatment with high-dose melphalan and autologous stem cell support. A randomised NMSG trial (15/05)
Summary
|
|
EudraCT number |
2005-002756-18 |
Trial protocol |
SE DK IS FI EE |
Global completion date |
30 Apr 2010
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
18 Mar 2020
|
First version publication date |
18 Mar 2020
|
Other versions |
|
Summary report(s) |
Bortezomib consolidation after autologous stem cell transplantation in multiple myeloma |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.